Testing effectiveness (Phase 2)Study completedNCT03443128What this trial is testingVinorelbine for Recurrent ALCL-2017Who this might be right forAnaplastic Large Cell LymphomaVinorelbine Children's Cancer Group, China 20
Testing effectiveness (Phase 2)Study completedNCT00006125What this trial is testingCombination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaWho this might be right forLymphoma Alliance for Clinical Trials in Oncology
Early research (Phase 1)UnknownNCT00562068What this trial is testingAlemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell LymphomaWho this might be right forLymphomaSmall Intestine Cancer Cancer Research UK 30
Large-scale testing (Phase 3)Ended earlyNCT01132547What this trial is testingCyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for CancerWho this might be right forCancer University of South Florida 22
Early research (Phase 1)Study completedNCT00243087What this trial is testingInvestigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL)Who this might be right forLymphoma Boehringer Ingelheim 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT01352520What this trial is testingSGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)Who this might be right forCD-30 Positive Anaplastic Large T-cell Cutaneous LymphomaLymphoma, Primary Cutaneous Anaplastic Large CellLymphomatoid Papulosis+5 more M.D. Anderson Cancer Center 79
Testing effectiveness (Phase 2)Study completedNCT01336933What this trial is testingCombination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin LymphomaWho this might be right forAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaHepatosplenic T-cell Lymphoma+1 more University of Nebraska 34
Large-scale testing (Phase 3)Looking for participantsNCT07300514What this trial is testingGolidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell LymphomaWho this might be right forMaintenance Treatment of Peripheral T-cell Lymphoma Fudan University 136
Testing effectiveness (Phase 2)Study completedNCT00089011What this trial is testingTacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more Fred Hutchinson Cancer Center 150
Early research (Phase 1)Ended earlyNCT00101205What this trial is testingOxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or LymphomaWho this might be right forAngioimmunoblastic T-cell LymphomaB-cell Childhood Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic Leukemia+24 more National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00416351What this trial is testingClofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous TreatmentWho this might be right forLeukemiaLymphomaSmall Intestine Cancer Memorial Sloan Kettering Cancer Center 29
Not applicableStudy completedNCT00897923What this trial is testingImaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's LymphomaWho this might be right forLymphomaSmall Intestine Cancer Mayo Clinic 17
Not applicableStudy completedNCT02652715What this trial is testingSalvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-Cell LymphomaAdult T-Cell Leukemia/LymphomaAnaplastic Large Cell Lymphoma+29 more Mayo Clinic 29
Testing effectiveness (Phase 2)Study completedNCT00078858What this trial is testingMycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more Fred Hutchinson Cancer Center 37
Not applicableWithdrawnNCT00499668What this trial is testingAprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With CancerWho this might be right forMyeloproliferative DisordersLeukemiaLymphoma+5 more Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01093586What this trial is testingDonor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+73 more Case Comprehensive Cancer Center 14
Early research (Phase 1)Study completedNCT00004241What this trial is testing17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or SarcomaWho this might be right forAIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+50 more National Cancer Institute (NCI) 60
Not applicableStudy completedNCT02902874What this trial is testingStudy of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +Who this might be right forALCL Gustave Roussy, Cancer Campus, Grand Paris 185
Not applicableUnknownNCT05907447What this trial is testingA Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological TypesWho this might be right forLymphomaExtranodal LymphomaDiffuse Large B Cell Lymphoma+6 more Ruijin Hospital 10,000
Not applicableStudy completedNCT01390597What this trial is testingBiomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell NeoplasmsWho this might be right forLymphoma Eastern Cooperative Oncology Group 32